One hundred tests. One sealed roll
100 → 1
A single test, end to end.
Four steps. Each automates or designs out a failure mode in current LFAs.
01
Feed
Advance a fresh strip from the sealed roll.
Buffer handling is automated. Designed to remove wrong buffer volume, wrong order, and wrong timing across the full 100-test roll lifetime.
02
Separate
Separate the strip from the dispenser.
Sample can only be applied after separation. Biosafety by design, not by instruction.
03
Dose
Apply fingerstick blood or urine to the sample pad. The assay starts automatically once enough sample is present.
No vial to uncap, no timing to measure, no external reagent to handle. An underfilled test will not start, removing a common cause of invalid or false-negative results.
04
Read
The result appears within minutes. Read by eye, handheld reader, or kiosk.
Quantitative digital readout removes dependence on lighting, operator fatigue, or time of read. The result is private to the user after the visual read window closes; digital audit by the reader is preserved.
Three modes of use.
One consumable, three deployment contexts. Handheld in the field, handheld with reader in clinics, kiosk for self-service.
Handheld, visual
For fieldwork and outreach where infrastructure is limited. Visual readout, no electronics. 100 tests per roll, no external buffer, no cold chain. Designed to run the full roll without recalibration.
Handheld, with reader
For clinical settings. The dispenser pairs with a quantitative digital reader for objective readout, digital record, and clinical workflow integration. One reader serves the full assay menu.
Installed kiosk
For self-service access. The handheld dispenser docks into the kiosk to refill the strip supply, so the same consumable serves all three modes. Zero human interaction reduces stigma and access barriers documented for HIV and STI testing, extending the privacy-layer rationale to the deployment level. Standard healthcare data formats turn individual tests into real-time regional surveillance data, pseudonymized at the source.
Built for blood-donor screening.
The screening panel covers HIV, hepatitis B, hepatitis C, and syphilis.
- HIV
- Hepatitis B
- Hepatitis C
- Syphilis
Donor screening is the first indication, not the limit.
One platform, many panels.
- One reader runs the full assay menu.
- A new test is a chemistry and software change, not a new tooling cycle, so every assay expands the roll catalog without new hardware.
- The format makes multiplex panels practical, including combinations a dedicated cassette would never justify. One example is the WHO triple panel for HIV, hepatitis B, and syphilis, prequalified for the first time in 2025.